1. Home
  2. ASYS vs MOLN Comparison

ASYS vs MOLN Comparison

Compare ASYS & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

N/A

Current Price

$13.19

Market Cap

164.5M

Sector

Technology

ML Signal

N/A

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$4.88

Market Cap

158.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ASYS
MOLN
Founded
1981
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
158.9M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ASYS
MOLN
Price
$13.19
$4.88
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
271.8K
1.6K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
$285.71
P/E Ratio
$1,295.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$3.36
52 Week High
$18.59
$5.36

Technical Indicators

Market Signals
Indicator
ASYS
MOLN
Relative Strength Index (RSI) 49.47 58.41
Support Level $11.60 $3.50
Resistance Level $13.26 $5.36
Average True Range (ATR) 0.74 0.18
MACD 0.11 -0.01
Stochastic Oscillator 59.17 54.95

Price Performance

Historical Comparison
ASYS
MOLN

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: